(Q38440408)

3 September 2017

1 reference

title

Relationship between adiponectin, obesity and insulin resistance (English)

1 reference

3 September 2017

0 references

1 reference

Guilherme Ardenghi Balsan

1

1 reference

3 September 2017

José Luiz da Costa Vieira

2

1 reference

3 September 2017

Aline Marcadenti de Oliveira

3

1 reference

3 September 2017

Vera Lúcia Portal

4

1 reference

3 September 2017

1 January 2015

1 reference

Revista da Associação Médica Brasileira

3 September 2017

1 reference

3 September 2017

61

1 reference

3 September 2017

1

1 reference

3 September 2017

72-80

1 reference

Obesity and disease activity in juvenile idiopathic arthritis

3 September 2017

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Lack of association between body mass index and plasma adiponectin levels in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin and cardiovascular disease: response to therapeutic interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin: from obesity to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin: mechanistic insights and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Oligomerization state-dependent elevations of adiponectin in chronic daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

The role of adiponectin in human vascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Chemokines control fat accumulation and leptin secretion by cultured human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

The cellular and signaling networks linking the immune system and metabolism in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin, obesity, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Inflammatory cytokines in vascular dysfunction and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin actions in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Diabesity: an overview of a rising epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

The link between obesity and albuminuria: adiponectin and podocyte dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Adiponectin in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Circulating adiponectin concentrations in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F1806-9282.61.01.072

10.1590/1806-9282.61.01.072

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference